SuperGen to Announce 2011 First Quarter Financial Results on April 27, 2011
20 Abril 2011 - 5:00AM
Business Wire
SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated
to discovery and development of novel cancer therapies, announced
that it will release its 2011 first quarter financial results on
Wednesday, April 27, 2011. SuperGen's management team will provide
details of the Company's financial results and any revised outlook
for the future.
A press release will be issued following the close of the market
on April 27th. The Company will host a webcast conference call to
discuss the results at 4:30 p.m. ET. A live webcast of the call
will be available in the Investor Events section of the Company's
Web site at www.supergen.com. A webcast replay of the live
conference call will be available shortly following the event.
Alternatively, you may access a replay of the conference call by
dialing (800) 642-1687 (domestic) and (706) 645-9291
(international); replay passcode number is 61104562. The webcast
replay and conference call replay will be available for 30
days.
About SuperGen
SuperGen is a pharmaceutical company dedicated to discovery and
development of novel cancer therapeutics in epigenetic and cell
signaling modulation. The Company develops products through
biochemical and clinical proof of concept to partner for further
development and commercialization. On April 6, 2011 SuperGen
entered into a definitive merger agreement to acquire Astex
Therapeutics Limited, a UK based biotechnology company. The
transaction is subject to customary regulatory, legal and
shareholder approvals. For more information about SuperGen, please
visit http://www.supergen.com.
Supergen, Inc. (MM) (NASDAQ:SUPG)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Supergen, Inc. (MM) (NASDAQ:SUPG)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Supergen, Inc. (MM) (NASDAQ): 0 recent articles
Más de SuperGen, Inc. Artículos de Noticias